The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kakturskiy L.V.

Research Institute of Human Morphology

Mikhaleva L.M.

A.P. Avtsyn Research Institute of Human Morphology

Mishnev O.D.

Russian National Research Medical University named after N.I. Pirogov

Zairatyants O.V.

Research Institute of Human Morphology;
Moscow State Medical and Dental University named after A.I. Evdokimov

Kurilina E.V.

Myasnikov National Medical Research Center of Cardiology

Komlev A.E.

Chazov National Research Center of Cardiology

Takotsubo syndrome (stress-induced cardiomyopathy)

Authors:

Kakturskiy L.V., Mikhaleva L.M., Mishnev O.D., Zairatyants O.V., Kurilina E.V., Komlev A.E.

More about the authors

Read: 43042 times


To cite this article:

Kakturskiy LV, Mikhaleva LM, Mishnev OD, Zairatyants OV, Kurilina EV, Komlev AE. Takotsubo syndrome (stress-induced cardiomyopathy). Russian Journal of Archive of Pathology. 2021;83(1):5‑11. (In Russ.)
https://doi.org/10.17116/patol2021830115

References:

  1. Satoh H, Tateishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M, eds. Clinical aspects of myocardial injury: from ischemia to heart failure. Tokyo: Kagakuhyouronsya Co; 1990.
  2. Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E. Current state of knowledge on takotsubo syndrome: a position statement from the taskforce on takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8-27.  https://doi.org/10.1002/ejhf.424
  3. Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy — a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 2008;5(1):22-29.  https://doi.org/10.1038/ncpcardio1066
  4. Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032-2046. https://doi.org/10.1093/eurheartj/ehy076
  5. Haghi D, Athanasiadis A, Papavassiliu T, Suselbeck T, Fluechter S, Mahrholdt H, Borggrefe M, Sechtem U.Right ventricular involvement in takotsubo cardiomyopathy. Eur Heart J. 2006;27(20): 2433-2439. https://doi.org/10.1093/eurheartj/ehl274
  6. Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the «broken heart syndrome». Clin Res Cardiol. 2009;98(7):457-462.  https://doi.org/10.1007/s00392-009-0028-y
  7. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539-548.  https://doi.org/10.1056/NEJMoa043046
  8. de Souza F, Altenburg Odebrecht Curi Gismondi R, Henriques Cunha Neto S, de Mattos MA. Takotsubo-like cardiomyopathy and extra-adrenal pheochromocytoma: case report and literature review. Clin Res Cardiol. 2008;97(6):397-401.  https://doi.org/10.1007/s00392-007-0638-1
  9. Borchert T, Hübscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, Tiburcy M, Liaw NY, Li Y, Haas J, Sossalla S, Huber MA, Cyganek L, Jacobshagen C, Dressel R, Raaz U, Nikolaev VO, Guan K, Thiele H, et al. Catecholamine-dependent β-adrenergic signaling in a pluripotent stem cell model of takotsubo cardiomyopathy. J Am Coll Cardiol. 2017;70(8):975-991.  https://doi.org/10.1016/j.jacc.2017.06.061
  10. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14(9):1137-1149. https://doi.org/10.4158/EP.14.9.1137
  11. Kume T, Akasaka T, Kawamoto T, Yoshitani H, Watanabe N, Neishi Y, Wada N, Yoshida K. Assessment of coronary microcirculation in patients with takotsubo-like left ventricular dysfunction. Circ J. 2005;69(8):934-939.  https://doi.org/10.1253/circj.69.934
  12. Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of takotsubo syndrome. Nat Rev Cardiol. 2015;12(7):387-397.  https://doi.org/10.1038/nrcardio.2015.39
  13. Jaguszewski M, Osipova J, Ghadri JR, Napp LC, Widera C, Franke J, Fijalkowski M, Nowak R, Fijalkowska M, Volkmann I, Katus HA, Wollert KC, Bauersachs J, Erne P, Lüscher TF, Thum T, Templin C. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur Heart J. 2014;35(15):999-1006. https://doi.org/10.1093/eurheartj/eht392
  14. Uchida Y, Egami H, Uchida Y, Sakurai T, Kanai M, Shirai S, Nakagawa O, Oshima T. Possible participation of endothelial cell apoptosis of coronary microvessels in the genesis of takotsubo cardiomyopathy. Clin Cardiol. 2010;33(6):371-377.  https://doi.org/10.1002/clc.20777
  15. Gräni C, Grunwald C, Windecker S, Siontis GCM. Coronary artery anomaly in takotsubo cardiomyopathy: cause or innocent bystander? Tex Heart Inst J. 2020;47(1):44-46.  https://doi.org/10.14503/THIJ-18-6809
  16. Spina M, Centola M, Verzoni A, Lombardi F. Congenital coronary anomalies in takotsubo-like syndrome: a rare association. J Cardiovasc Med. (Hagerstown). 2013;14(1):66-68.  https://doi.org/10.2459/JCM.0b013e3283515c46
  17. Zhang Z, Jin S, Teng X, Duan X, Chen Y, Wu Y. Hydrogen sulfide attenuates cardiac injury in takotsubo cardiomyopathy by alleviating oxidative stress. Nitric Oxide. 2017;67:10-25.  https://doi.org/10.1016/j.niox.2017.04.010
  18. Dhar S, Koul D, Subramanian S, Bakhshi M. Transient apical ballooning: sheep in wolves’ garb. Cardiol Rev. 2007;15(3):150-153.  https://doi.org/10.1097/01.crd.0000262752.74597.15
  19. Singh K, Carson K, Usmani Z, Sawhney G, Shah R, Horowitz J. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol. 2014;174(3):696-701.  https://doi.org/10.1016/j.ijcard.2014.04.221
  20. Shilova AS, Shmotkina AO, Yafarova AA, Gilyarov MYu. Sindrom Takotsubo: sovremennye predstavleniya o patogeneze, rasprostranennosti i prognoze. Ratsional’naya farmakoterapiya v kardiologii. 2018;14(4):598-604. (In Russ.).
  21. Dalia T, Amr BS, Agrawal A, Gautam A, Sethapati VR, Kvapil J. A rare case of sudden death in a patient with takotsubo cardiomyopathy secondary to cardiac rupture. Case Rep Cardiol. 2019;2019:5404365. https://doi.org/10.1155/2019/5404365
  22. Tornvall P, Collste O, Ehrenborg E, Järnbert-Petterson H. A case-control study of risk markers and mortality in takotsubo stress cardiomyopathy. J Am Coll Cardiol. 2016;67(16):1931-1936. https://doi.org/10.1016/j.jacc.2016.02.029
  23. Akashi YJ, Tejima T, Sakurada H, Matsuda H, Suzuki K, Kawasaki K, Tsuchiya K, Hashimoto N, Musha H, Sakakibara M, Nakazawa K, Miyake F. Left ventricular rupture associated with takotsubo cardiomyopathy. Mayo Clin Proc. 2004;79(6):821-824.  https://doi.org/10.4065/79.6.821
  24. Kumar S, Kaushik S, Nautiyal A, Choudhary SK, Kayastha BL, Mostow N, Lazar JM. Cardiac rupture in takotsubo cardiomyopathy: a systematic review. Clin Cardiol. 2011;34(11):672-676.  https://doi.org/10.1002/clc.20957
  25. Pasupathy S, Tavella R, Beltrame JF. Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management. Circulation. 2017;135(16):1490-1493. https://doi.org/10.1161/CIRCULATIONAHA.117.027666
  26. Sung BH, Ching M, Izzo JL Jr, Dandona P, Wilson MF. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women. J Hypertens. 1999;17(4):523-528.  https://doi.org/10.1097/00004872-199917040-00010
  27. Mitchell A, Marquis F. Can Takotsubo cardiomyopathy be diagnosed by autopsy? Report of a presumed case presenting as cardiac rupture. BMC Clin Pathol. 2017;17:4.  https://doi.org/10.1186/s12907-017-0045-0
  28. Wilson HM, Cheyne L, Brown PAJ, Kerr K, Hannah A, Srinivasan J, Duniak N, Horgan G, Dawson DK. Characterization of the myocardial inflammatory response in acute stress-induced (Takotsubo) cardiomyopathy. JACC Basic Transl Sci. 2018;3(6):766-778.  https://doi.org/10.1016/j.jacbts.2018.08.006
  29. Nakano T, Onoue K, Nakada Y, Nakagawa H, Kumazawa T, Ueda T, Nishida T, Soeda T, Okayama S, Watanabe M, Kawata H, Kawakami R, Horii M, Okura H, Uemura S, Hatakeyama K, Sakaguchi Y, Saito Y. Alteration of β-adrenoceptor signaling in left ventricle of acute phase takotsubo syndrome: a human study. Sci Rep. 2018;8(1):12731. https://doi.org/10.1038/s41598-018-31034-z
  30. Izgi C, Ray S, Nyktari E, Alpendurada F, Lyon AR, Rathore S, Baksi AJ. Myocardial edema in takotsubo syndrome mimicking apical hypertrophic cardiomyopathy: An insight into diagnosis by cardiovascular magnetic resonance. Heart Lung. 2015;44(6):481-485.  https://doi.org/10.1016/j.hrtlng.2015.07.008
  31. Caforio AL, Tona F, Vinci A, Calabrese F, Ramondo A, Cacciavillani L, Corbetti F, Leoni L, Thiene G, Iliceto S, Angelini A. Acute biopsy-proven lymphocytic myocarditis mimicking takotsubo cardiomyopathy. Eur J Heart Fail. 2009;11(4):428-431.  https://doi.org/10.1093/eurjhf/hfp008
  32. Sachdeva J, Dai W, Kloner RA. Experimental model of takotsubo’s cardiomyopathy. J Am Heart Assoc. 2014;3:e000921. https://doi.org/10.1161/JAHA.114.000921
  33. Kawai S, Shimada T. Inflammation in takotsubo cardiomyopathy? Inquiry from «Guidelines for Diagnosis and Treatment of Myocarditis (JCS 2009)». J Cardiol. 2014;63(4):247-249.  https://doi.org/10.1016/j.jjcc.2013.11.002
  34. Scally C, Abbas H, Ahearn T, Srinivasan J, Mezincescu A, Rudd A, Spath N, Yucel-Finn A, Yuecel R, Oldroyd K, Dospinescu C, Horgan G, Broadhurst P, Henning A, Newby DE, Semple S, Wilson HM, Dawson DK. Myocardial and systemic inflammation in acute stress-induced (Takotsubo) cardiomyopathy. Circulation. 2019;139(13):1581-1592. https://doi.org/10.1161/CIRCULATIONAHA.118.037975
  35. Tsuruda T, Yoshikawa N, Kai M, Yamaguchi M, Toida R, Kodama T, Kajihara K, Kawabata T, Nakamura T, Sakata K, Hatakeyama K, Gi T, Asada Y, Tono T, Kitamura K, Ikeda R. The cytokine expression in patients with cardiac complication after immune checkpoint inhibitor therapy. Intern Med. 2020 Sep 19.  https://doi.org/10.2169/internalmedicine.5317-20
  36. Chadha S. ‘COVID-19 pandemic’ anxiety-induced takotsubo cardiomyopathy. QJM. 2020;113(7):488-490.  https://doi.org/10.1093/qjmed/hcaa135
  37. Meyer P, Degrauwe S, Van Delden C, Ghadri JR, Templin C. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020;41(19):1860. https://doi.org/10.1093/eurheartj/ehaa306
  38. Solano-López J, Sánchez-Recalde A, Zamorano JL. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome. Eur Heart J. 2020;41(32):3106. https://doi.org/10.1093/eurheartj/ehaa390
  39. Hendren NS, Drazner MH, Bozkurt B, Cooper LT, Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141(23):1903-1914. https://doi.org/10.1161/CIRCULATIONAHA.120.047349
  40. Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, De Cobelli F, Tresoldi M, Cappelletti AM, Basso C, Godino C, Esposito A. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861-1862. https://doi.org/10.1093/eurheartj/ehaa286

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.